PMS-METHYLPHENIDATE CR
PHARMASCIENCE INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of PMS-METHYLPHENIDATE CR in Canada?
Yes. PMS-METHYLPHENIDATE CR 15MG has an active shortage reported to Health Canada (last updated July 27, 2026).
Why is PMS-METHYLPHENIDATE CR not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will PMS-METHYLPHENIDATE CR be available again?
The manufacturer's estimated resolution date is November 15, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
ADHD Medication Shortage in Canada: What to Know
Why ADHD medications go into shortage in Canada more often than most drug classes, which ones are most affected, and what to do if yours is short-supplied.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
PMS-METHYLPHENIDATE
PHARMASCIENCE INC
PHL-METHYLPHENIDATE
PHARMEL INC
METHYLPHENIDATE TAB 10MG
TECHNILAB PHARMA INC.
RATIO-METHYLPHENIDATE
TEVA CANADA LIMITED
METHYLPHENIDATE TAB 20MG
TECHNILAB PHARMA INC.
CONCERTA
JANSSEN INC
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
Estimated Resolution
2026-11-15
~2 months remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02536951
Strength
15MG
Dosage Form
CAPSULE (EXTENDED RELEASE)
Route
ORAL
Active Ingredient
METHYLPHENIDATE HYDROCHLORIDE
Tier
Unrated
Last Updated
2026-07-27
Reason for Shortage
Disruption of the manufacture of the drug.
Other Products from PHARMASCIENCE INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02303299
DIN 01999648
DIN 01999656
DIN 02028174
DIN 02025337
650MG · DIN 02527901
81MG · DIN 02433044
81MG · DIN 02244993
81MG · DIN 02394790
80MG · DIN 02009013
80MG · DIN 02238545
40MG · DIN 02399393